Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Laura L. Murray. (2017) Design fluency subsequent to onset of aphasia: a distinct pattern of executive function difficulties?. Aphasiology 31:7, pages 793-818.
Read now
Read now
Robert Fucetola, LisaT. Connor, MichaelJ. Strube & Maurizio Corbetta. (2009) Unravelling nonverbal cognitive performance in acquired aphasia
. Aphasiology 23:12, pages 1418-1426.
Read now
Read now
Katrina Keil & Alfred W. Kaszniak. (2002) Examining executive function in individuals with brain injury: A review. Aphasiology 16:3, pages 305-335.
Read now
Read now
G. Goldenberg, H. Dettmers, C. Grothe & J. Spatt. (1994) Influence of linguistic and non-linguistic capacities on spontaneous recovery of aphasia and on success of language therapy. Aphasiology 8:5, pages 443-456.
Read now
Read now
Articles from other publishers (9)
Petru Fabian Lungu, Corina Miruna Lungu, Alin Ciobica, Ioana Miruna Balmus, Raluca Vitalaru, Ioannis Mavroudis, Romeo Dobrin, Mirela Cimpeanu & Irina Luciana Gurzu. (2024) The Effect of Antipsychotics on Cognition in Schizophrenia—A Current Narrative Review. Brain Sciences 14:4, pages 359.
Crossref
Crossref
임경열. (2012) The Relationship between Executive Attention and Language Severity or Working Memory Spanin Persons with Aphasia. Journal of speech-language & hearing disorders 21:3, pages 445-463.
Crossref
Crossref
Jamie F. Mayer & Laura L. Murray. (2012) Measuring working memory deficits in aphasia. Journal of Communication Disorders 45:5, pages 325-339.
Crossref
Crossref
M. Riedel, R. Schennach‐Wolff, R. Musil, S. Dehning, A. Cerovecki, M. Opgen‐Rhein, J. Matz, F. Seemüller, M. Obermeier, R. R. Engel, N. Müller, H.‐J. Möller & I. Spellmann. (2010) Neurocognition and its influencing factors in the treatment of schizophrenia—effects of aripiprazole, olanzapine, quetiapine and risperidone. Human Psychopharmacology: Clinical and Experimental 25:2, pages 116-125.
Crossref
Crossref
Michael Riedel & I. Spellmann. 2010. Schizophrenie — Zukunftsperspektiven in Klinik und Forschung. Schizophrenie — Zukunftsperspektiven in Klinik und Forschung
205
217
.
Sofie A.M.K. Houthoofd, Manuel Morrens & Bernard G.C. Sabbe. (2008) Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder. Clinical Therapeutics 30:9, pages 1565-1589.
Crossref
Crossref
Ilja Spellmann, Norbert Müller, Richard Musil, Peter Zill, Anette Douhet, Sandra Dehning, Anja Cerovecki, Brigitta Bondy, Hans-Jürgen Möller & Michael Riedel. (2008) Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics. European Archives of Psychiatry and Clinical Neuroscience 258:6, pages 335-344.
Crossref
Crossref
Michael Riedel, Norbert Müller, Ilja Spellmann, Rolf R. Engel, Richard Musil, Rosamaria Valdevit, Sandra Dehning, Anette Douhet, Anja Cerovecki, Martin Strassnig & Hans-Jürgen Möller. (2007) Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 257:7, pages 402-412.
Crossref
Crossref
Michael Riedel, Ilja Spellmann, Martin Strassnig, Anette Douhet, Sandra Dehning, Markus Opgen-Rhein, Rosamaria Valdevit, Rolf R. Engel, Nikolaus Kleindienst, Norbert Müller & Hans-Jürgen Möller. (2007) Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms. European Archives of Psychiatry and Clinical Neuroscience 257:6, pages 360-370.
Crossref
Crossref